Cancer's shape-shifting tricksters, revealed!
Some cancers have a sneaky ability to transform and mimic other cells, making them incredibly difficult to treat. These shape-shifting tumors, particularly carcinomas, can change their cellular identity and even resemble cells from different organs, like skin. But why is this a problem? Well, it's like trying to catch a chameleon that keeps changing colors. The challenge lies in developing effective therapies when the target keeps shifting.
Professor Christopher Vakoc from Cold Spring Harbor Laboratory (CSHL) sheds light on this mysterious behavior, stating, "These tumors are masters of disguise, morphing their cellular identity." And here's where it gets fascinating: some of these shapeshifters might even change to dodge cancer treatments, like a cunning escape artist.
In a recent breakthrough, Vakoc's team published two studies in prestigious journals, Nature Communications and Cell Reports. They've identified proteins that control whether pancreatic cancer cells stay true to their form or begin to mimic skin cells. Additionally, they've uncovered the crystal structure of proteins crucial in tuft cell lung cancer.
This journey began in 2018 when Vakoc and his colleagues discovered tuft cell lung cancer. They were exploring epigenetic factors, the behind-the-scenes directors of gene activity and cellular identity. Now, they've potentially found an epigenetic therapy that could halt cancer growth, a true eureka moment!
Vakoc's mission is to uncover the 'master regulators' of cellular identity, which could be the key to new treatments. Imagine targeting these regulators with medicines, much like hormone therapies for breast and prostate cancers. But there's a catch: ensuring these treatments don't harm healthy cells.
In their latest studies, Vakoc's team focused on specificity, aiming to target cancer without causing collateral damage. Their efforts set a new standard for precision in cancer treatment. And it's not just about new medicines; it's about understanding cellular identity at its core, paving the way for better care.
Cold Spring Harbor Laboratory, a renowned research institution with a rich history dating back to 1890, continues to push the boundaries of biomedical knowledge. With a team of over 600 scientists and eight Nobel Prize winners, they are dedicated to advancing cancer research and education.
